United Kingdom · Series A startup

Who invested in Memento Medicines

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 5 months ago

Funding summaryUpdated 26 Oct 2026

$93Mraised across 1 round since 2026, from 1 source

Latest round
Series A, $93MJun 2026
Investors
4
See who backed them

The rounds

  1. Jun 2026
    Series A$93M

    Source recordedSEC filing: $38M sold

Everyone who backed them

RA Capital ManagementPrivate equity1round
Forbion Capital PartnersPrivate equity1round
Samsara BioCapitalVC firm1round
SanofiInvestment firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Memento Medicines

Who invested in Memento Medicines?

Memento Medicines's investors include RA Capital Management, Forbion Capital Partners, Samsara BioCapital and Sanofi.

How much has Memento Medicines raised?

Memento Medicines has raised $93M across 1 round since 2026.

When did Memento Medicines last raise?

Memento Medicines's most recent round was a Series A of $93M in Jun 2026.

What was Memento Medicines's biggest round?

Its most recent round, $93M in Jun 2026, is also its largest on record.

Who backed Memento Medicines first?

Memento Medicines's first round on record, in Jun 2026, was backed by RA Capital Management, Forbion Capital Partners and Samsara BioCapital and 1 others.

What stage is Memento Medicines at?

Memento Medicines's latest named round is a Series A, in Jun 2026.

Where is Memento Medicines based?

Memento Medicines is based in the United Kingdom.

Companies like Memento Medicines

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.